And new drug against diabetes capable at the same time of protect the heart and be effective against obesity has received the green light from the Food and Drug Administration, the American body that regulates the drug market.
The new molecule, which It’s called tirzepatide (Tzt), was studied by a team of Italian researchers from the UniCamillus University of Rome, that of Salerno and the Inrca-Irccs of Ancona. The Italian study can be read in the scientific journal Cardiovascular Diabetology.
New drug against diabetes: lowers inflammation levels, protecting the heart
The working group carried out a meta-analysis on the effectiveness of Tzt at a cardiovascular level. The results demonstrated strong protective effects on the heart. Tirzepatide reduces the risk of serious cardiovascular events, as well as promoting cardiac contractility.
And’great news for diabetics living with a higher risk of developing cardiovascular disease. The protective effects on the heart are linked to the anti-inflammatory action of this molecule, which is also capable of counteracting the consequences of oxidative stress.
New drug against diabetes also useful against obesity
The new drug is useful against type 2 diabetes e it also guarantees effects against obesity. According to experts it could replace the semaglutidethe famous active ingredient of anti-diabetes drugs that have hit the headlines around the world for its use as a powerful slimming agent.
In fact, it could become the most prescribed medicine in cases of diabetes and obesity. Its protective effect against cardiovascular diseases could also make it a drug for heart patients.
Another Italian drug against diabetes
Meanwhile, the University of Pisa has developed another new drug for the treatment of type 2 diabetes, which is called MELODIE. It is based on a small molecule, which combines the antidiabetic effect of metformin, the best-selling oral antidiabetic drug, with the cardiovascular protective properties of hydrogen sulfide. Those who suffer from diabetes have a high risk of heart disease.